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summary 
Six new benzopyran derivatives were synthesized by reduction reaction and Michael reaction 
from malloapelta B. Their structures were determined as 8-(1’-oxo-butyl)-5,7-dimethoxy-2,2-
dimethyl-2H-1-benzopyran (2), 8-(1’-oxo-3’(R)-methyl-4’-acetyl-5’-oxo-hexyl)-5,7-dimethoxy-
2,2-dimethyl-2H-1-benzopyran (3), 8-(1’-oxo-3’(R)-methyl-4’(S/R)-(methyl fomiate)-5’-oxo-
hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (4,4’), 8-(1’-oxo-3’(R)-methyl-4’(S/R)-(ethyl 
formiate)-5’-oxo-hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (5,5’) by spectroscopic 
data, including two-dimensional NMR techniques and ESI spectrum. 
Keywords: Malloapelta B; Michael reaction; reduction reaction; 5,7-dimethoxy-2,2-dimethyl-
2H-1-benzopyran. 
I - introduction 
Malloapelta B (1), a new benzopyran 
derivative was isolated from the Vietnamese 
traditional medicinal plant Mallotus apelta 
(Lour.) Muell.-Arg. [1]. It shows strong 
cytotoxic effect as well as strong activity against 
NF-B activation with IC50 value 0.54±0.05 µM. 
This compound is continued studying further for 
cancer treatment [2, 3]. To investigate the 
relations between the structures and their 
bioactivities as well as probably find new 
derivatives having stronger bioactivities, we 
have synthesized a series of its derivatives.  
As a part of our research, we report herein 
six new derivatives synthesized by reduction 
reaction and Michael reaction. Their structures  
were determined as 8-(1’-oxo-butyl)-5,7-
dimethoxy-2,2-dimethyl-2H-1-benzopyran (2), 
8-(1’-oxo-3’(R)-methyl-4’-acetyl-5’-oxo-
hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-
benzopyran (3), 8-(1’-oxo-3’(R)-methyl-4’(S/R)-
(methyl formiate)-5’-oxo-hexyl)-5,7-dimethoxy 
-2,2-dimethyl-2H-1-benzopyran (4, 4’), 8-(1’-
oxo-3’(R)-methyl-4’(S/R)-(ethyl formiate)-5’-
oxo-hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-
benzopyran (5, 5’) by the NMR and MS spectra. 
The relationships between their structures and 
cytotoxicities will be reported elsewhere. 
II - Experimental 
Materials and methods 
Material 
Malloapelta B was isolated from Mallotus 
apelta (Lour.) Muell.-Arg.. The reagents were 
purchased of Aldrich Co. Solvents were distilled 
prior to use. 
General Experimental Procedures 
The Electronspray Ionization (ESI) mass 
spectrum was obtained by using an AGILENT 
1100 LC-MSD Trap spectrometer. The 1H-NMR 
(500 MHz) and 13C-NMR (125 MHz) spectra 
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were recorded on a Bruker AM500 FT-NMR 
spectrometer using TMS as the internal 
standard. Column chromatography (CC) was 
performed on silica gel (Kieselgel 60, 70-230 
mesh and 230-400 mesh, Merck). TLC was 
performed with Thin layer Art 5562 DC-
Alurolle Kieselgel made by Merck Co.   
The synthesis of  8-(1’- oxo-butyl)-5,7-dime-
thoxy-2,2-dimethyl-2H-1-benzopyran (2) 
20 mg (0.62 mmol) NaBH4 was added 
slowly to a solution of 150 mg (0.52 mmol) 
malloapelta B with 15 ml MeOH in a 40 ml 
round-flask placed on a magnetic stirrer. The 
reaction was kept at room temperature for 4 h. 
The reaction mixture was extracted with mixture 
CHCl3/H2O. The CHCl3 extract was separated 
by column chromatography over silica gel 
eluted with n-hexane-acetone (10:1) to afford 
128 mg of the reduced product 2, yield 85%. 
1H-NMR (500 MHz, MeOD),  (ppm): 5.44 
(1H, d, J = 10.5 Hz, H-3), 6.56 (1H, d, J = 10.5 
Hz, H-4), 6.00 (1H, s,  H-6), 2.72 (2H, m, H-2’), 
1.70 (2H, m, H-3’), 0.95 (3H, t, J = 6.5 Hz, H-
4’), 3.70 (3H, 7-OCH3), 3.83 (3H, 5-OCH3), 
1.39 (6H, s, H-11, H-12). 
13C-NMR (125 MHz, MeOD),  (ppm): 76.7 
(s, C-2), 126.6 (d, C-3), 116.4 (d, C-4), 157.6 (s, 
C-5), 87.8 (d, C-6), 156.5 (s, C-7), 113.6 (s, C-
8), 151.5 (s, C-9), 104.2 (s, C-10), 27.7 (q, C-11, 
C-12), 204.2 (s, C-1’), 47.0 (t, C-2’), 17.6 (t, C-
3’), 13.9 (q, C-4’), 55.7 (q, 7-OCH3), 55.8 (q, 5-
OCH3). 
ESI m/z: 291 [M+H]+ (C17H23O4). 
The synthesis of 8-(1’-oxo-3’(R)-methyl-4’-
acetyl-5’-oxo-hexyl)-5,7-dimethoxy-2,2-
dimethyl-2H-1-benzopyran (3) 
A mixture of 150 mg (0.52 mmol) 
malloapelta B and acetylacetone in 15ml MeOH 
added 200 µL NaOH20% was placed on a 
magnetic stirrer in a 40 ml round-flask. The 
mixture was maintained at room temperature in 
12h. Removal of the solvent afforded a residue 
that was purified by column chromatography 
over silica gel eluted with n-hexane-acetone 
(6:1) to give 138 mg product 3, yield 68%. 
1H-NMR (500 MHz, MeOD),  (ppm): 5.44 
(1H, d, J = 10.5 Hz, H-3), 6.55 (1H, d, J = 10.5 
Hz, H-4), 5.99 (1H, s, H-6), 1.39 (3H, s, H-11), 
1.37 (3H, s, H-12), 2.71 (1H, dd,  J = 17.0, 8.5 
Hz, Ha-2’), 2.74 (1H, dd, J = 17.0, 4.0 Hz, Hb-
2’), 2.80 (1H, m, H-3’), 3.84 (1H d, J = 9.0 Hz, 
H-4’), 1.01 (3H, d, J = 6.5 Hz, H-5’), 2.18 (3H, 
s, H-7’), 2.19 (3H, s, H-9’), 3.83 (3H, s, 7-
OCH3), 3.78 (3H, s, 5-OCH3). 
13C-NMR (125 MHz, MeOD),  (ppm): 76.8 
(s, C-2), 126.7 (d, C-3), 116.3 (d, C-4), 156.7 (s, 
C-5), 87.8 (d, C-6), 157.6 (s, C-7), 113.2 (s, C-
8), 151.5 (s, C-9), 104.3 (s, C-10), 27.7 (q, C-11, 
C-12), 202.0 (s, C-1’), 48.7 (t, C-2’), 30.2 (d, C-
3’), 73. (d, C-4’), 17.7 (q, C-5’), 204.6 (s, C-6’), 
29.7 (q, C-7’), 204.6 (s, C-8’), 29.9 (q, C-9’), 
55.7 (q,  7-OCH3) and 55.7 (q, 5-OCH3). 
ESI m/z: 389 [M+H]+ (C22H29O6). 
The synthesis of 8-(1’-oxo-3’(R)-methyl-4’-
(S/R)-(methyl formiate)-5’-oxo-hexyl)-5,7-di-
methoxy-2,2-dimethyl-2H-1-benzopyran (4,4’)
A mixture of 150 mg (0.52 mmol) 
malloapelta B and acetoacetate methyl ester in 
15 ml MeOH added 20 mg CH3ONa was placed 
on a magnetic stirrer in a 40 ml round-flask. The 
mixture was maintained at room temperature 
overnight. Removal of the solvent afforded a 
residue that was purified by column 
chromatography over silica gel eluted with        
n-hexane-acetone (4:1) to give 148 mg the 
mixture of two optical isomers 4 and 4’, yield 
71%. 
1H-NMR (500 MHz, MeOD),  (ppm): 5.43 
(d, J = 10.5 Hz, H-3), 6.55 (d, J = 10.5 Hz, H-4), 
5.99 (s, H-6), 1.38 (s, H-11), 1.38 (s, H-12), 
2.82 - 2.92 (m, H-2’), 2.74 (m, H-3’), 3.56 (d, J
= 7.5 Hz, H-4’)/3.65 (d, J = 7.5 Hz, H-4’), 1.05 
(3H, s, H-5’)/1.06 (3H, s, H-5’), 2.46 (s, H-7’), 
3.71 (s, H-9’), 3.78 (s, OCH3), 3.83 (s, OCH3). 
13C-NMR (125 MHz, MeOD),  (ppm): 
76.88/76.91 (s, C-2), 126.69/126.69 (d, C-3), 
116.30/116.31 (d, C-4), 156.65/156.68 (s, C-5), 
87.80/87.86 (d, C-6), 157.60/157.60 (s, C-7), 
113.21/113.28 (s, C-8), 151.54/151.54 (s, C-9), 
104.24/104.24 (s, C-10), 27.65/27.65 (q, C-11), 
27.70/27.70 (q, C-12), 202.06/202.17 (s, C-1’), 
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48.71/48.96 (t, C-2’), 29.38/29.44 (d, C-3’), 
64.25/63.97 (d, C-4’), 17.28/17.84 (q, C-5’), 
29.64/29.44 (q, C-7’), 52.07/52.12 (q, C-9’), 
55.68/5.68 (q, 7-OCH3), 55.80/55.80 (q, 5-
OCH3). 
ESI m/z: 405 [M+H]+ (C22H29O7). 
The synthesis of 8-(1’-oxo-3’(R)-methyl-4’
(S/R)-(ethylformiate)-5’-oxo-hexyl)-5,7-dime-
thoxy-2,2-dimethyl-2H-1-benzopyran (5,5’)
A mixture of 150 mg (0.52 mmol) 
malloapelta B and acetoacetate ethyl ester in 15 
ml C2H5OH added 200 µL NaOH 20% was 
placed on a magnetic stirrer in a 40 ml round-
flask. The mixture was maintained at room 
temperature in 14 h. Removal of the solvent 
afforded a residue that was purified by column 
chromatography over silica gel eluted with n-
hexane-acetone (4:1) to give 152 mg the 
mixture of two optical isomers 5 and 5’, yield 
70%. 
1H-NMR (500 MHz, MeOD),  (ppm): 5.45 
(d, J = 10.5 Hz, H-3), 6.56 (d, J = 10.5 Hz, H-
4), 5.99 (s, H-6), 2.83 - 2.92 (m, H-2’), 2.74 (m, 
H-3’), 3.52 (d, J = 7.5 Hz, H-4’)/3.60 (d, J = 7.5 
H-4’), 1.05 (d, J = 6.5 Hz, H-5’)/1.06 (d, J =
6.5 Hz, H-5’), 2.24 (s, H = 7’), 4.17 (q, J = 6.5 
Hz, H-9’), 1.26 (t, J = 6.5 Hz, H-10’), 3.77 (s, 
7-OCH3), 3.83 (s, 5-OCH3). 
13C-NMR (125 MHz, MeOD),  (ppm): 
76.81/76.82 (s, C-2), 126.69/126.69 (d, C-3), 
116.30/116.80 (d, C-4), 156.63/156.67 (s, C-5), 
87.80/87.80 (d, C-6), 157.09/157.09 (s, C-7), 
113.26/113.34 (s, C-8), 151.51/151.51 (s, C-9), 
104.24/104.24 (s, C-10), 27.65/27.65 (q, C-11), 
27.70/27.70 (q, C-12), 202.13/202.21 (s, C-1’), 
48.77/48.99 (t, C-2’), 29.40/29.57 (d, C-3’), 
64.30/64.48 (d, C-4’), 17.35/17.80 (q, C-5’), 
203.36/203.38 (s, C-6’), 29.30/29.34 (q, C-7’), 
169.10/169.16 (s, C-8’), 61.10/61.09 (t, C-9’), 
14.12/14.13 (q, C-10’), 55.79/55.79 (q, OCH3), 
56.00/56.00 (s, OCH3). 
ESI m/z: 419 [M+H]+ (C23H31O7). 
III - RESULTS AND DISCUSSION 
Compound 2 was obtained as white crystals 
from the reduction reaction after being purified 
by column chromatography over silica gel. The 
synthetic process [4, 5] was illustrated as 
scheme 1. 
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The NMR spectra of 2 were similar to those 
of 1, except for the absence of the double bond 
signals at C-2’ and C-3’, and the additional of 
two methylene signals at C 47.0/17.6 and H
2.72 (m)/1.70 (m) in the NMR spectra of 2.
These changes were further confirmed by 
analysis of the proton-coupling constants and by 
the appearance of a quasi ion peak at m/z 291 
[M+H] (C17H22O4 + H) in the positive ESI 
spectrum of 2. Consequently, the structure of 2
was 8-(1’-oxo-butyl)-5,7-dimethoxy-2,2-
dimethyl-2H-1-benzopyran. 
Compounds 3, 4/4’, 5/5’ were obtained as 
white crystals by Michael reaction with 
acetylacetone, acetoacetate methyl ester, and 
acetoacetate ethyl ester as agents of the 
reactions, respectively. The synthetic process of 
these compounds [4, 5] was illustrated as 
scheme 2. 
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The 1H-NMR of 3 exhibited two doublets at 
 5.44 and 6.55 (J = 10.5 Hz), which were 
assigned to H-3 and H-4, respectively. A singlet 
of H-6 was at  5.99, two quaternary methyl 
groups at  1.37 and 1.39 as the singles, two 
methoxyl groups were at 3.78 and 3.83. The 
acetoacetyl group was determined to connect at 
C-3’ from the appearance of two methyl groups 
at  2.18 and 2.19, and a methine proton at 
3.84 (d, J = 9.0 Hz). In addition, the methyl 
group at  1.01 as a doublet (J = 6.5 Hz) also 
confirmed the acetoacetyl group attached to C-
3’. The 13C-NMR and DEPT spectra of 3
showed signals of 22 carbons. The two acetyl 
groups were confirmed at  204.6, 29.7/29.9. 
The methylene and methine carbons at  48.7
and 30.2, respectively evidenced the absence of 
the double bond. Furthermore, the ESI exhibited 
a quasi ion peak at m/z 389 [M+H], correspond 
to the molecular formula of C22H28O6. From the 
above data, compound 3 was determined to be 
8-(1’-oxo-3’(R)-methyl-4’-acetyl-5’-oxo-
hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-
benzopyran. 
Compounds 4/4’ and 5/5’ were obtained as 
two racemics, which were confirmed by the 
analysis of NMR data. All the NMR spectra of 
4/4’ and 5/5’ were similar to those of 3, except 
for the more appearance of the methoxy group 
(C 52.12/52.07 and H 3.71) instead of the 
methyl carbon at C 29.9/H 2.19). The 
stereochemistry at C-3’ of  4/4’ and 5/5’ were 
suggested to be (R) by comparing the chemical 
shifts and proton coupling constants of  4/4’ and 
5/5’ with those of 6-(methyl 1-oxo-3-hydroxy-
butyl ether)-5,7-dimethoxy-2,2-dimethyl-2H-1-
benzopyran and 6-(1-oxo-3-hydroxy-butyl)-
5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran 
[6], and with the similar structure reported in the 
literature [7]. In addition, the ESI spectra of 4/4’
and 5/5’ showed the ion peaks at m/z 405
[M+H]+ and 419 [M+H]+ corresponding to the 
molecular formula of C22H28O7 and C23H30O7,
respectively. Thus, compound 4/4’was 
determined to be a racemic of 8-(1’-oxo-3’(R)-
methyl-4’(S/R)-(methyl formiate)-5’-oxo-
hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-
benzopyran and  5/5’ was a racemic of 8-(1’-
oxo-3’(R)-methyl-4’(S/R)-(ethyl formiate)-5’-
oxo-hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-
benzopyran.  
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